Summit Financial’s Astera Labs ALAB Stock Holding History

Summit Financial’s Portfolio ALAB Stock Details ALAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.27M	Buy	12,981 +2,454	+23%	+$651K	0.07%	289
2026 Q1	$1.15M	Buy	+10,527	New	+$1.5M	0.01%	726

Other funds holding ALAB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Summit Financial's ALAB Position: Q2 2026 in Review

Summit Financial increased its Astera Labs (ALAB) stake by 23% in Q2 2026, buying an estimated $651K and bringing the position to 12,981 shares worth $6.27M. The position accounts for 0.07% of the portfolio, ranked #289.

Summit Financial first reported a position in ALAB in Q1 2026 and has held it in 2 quarters since. 988 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

Summit Financial held 12,981 shares of Astera Labs worth $6.27M as of Q2 2026.
Summit Financial bought 2,454 Astera Labs shares in Q2 2026, an estimated $651K.
Astera Labs made up 0.07% of Summit Financial's portfolio in Q2 2026, its #289 holding.
Summit Financial first reported a position in Astera Labs in Q1 2026 and has held it in 2 quarters since.
988 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Summit Financial's 13F filing for Q2 2026, filed 12 Aug 2026.